novavax covid - Search News

Order byBest matchMost fresh

Novavax’s COVID vaccine gets FDA approval

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's Covid-19 vaccine after more than a month of delay b

WebMD · 9h

FDA Approves Novavax COVID Vaccine With Restricted Use

· 2d · on MSN

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

· 5h

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant

The U.S. Senate plans to vote this week to bar California's landmark plan to end the sale of gasoline-only vehicles by 2035 that has been adopted by 11 other states, Majority Leader John Thune said on...

· 8h

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

· 9h

US regulators say annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved

· 2h

F.D.A. Poised to Restrict Access to Covid Vaccines

The Food and Drug Administration will permit Covid vaccines for adults over 65 and those with certain medical conditions in the fall, according to new regulatory standards detailed on Tuesday by agen...

· 6h

FDA sets new COVID booster guidelines for healthy adults under 65

· 1d

RFK Jr.’s FDA Severely Restricts COVID Vaccine Use

7hon MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at low risk," the agency said in an article published by The New England Journal of Medicine, authored by FDA Commissioner Dr. Martin Makary and his new top vaccines official, Dr. Vinay Prasad.

41mon MSN

The FDA is making it more difficult for Americans to get vaccinated for covid

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people getting the shot each year. “There may even be a ripple effect: public trust in vaccination in general has declined,” it says.

McKnight's Long-Term Care News1h

Older adults gain new COVID vaccine option as FDA approves protein-based shot

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by Novavax,

27mon MSN

New Trump vaccine policy limits access to COVID shots

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy.

STAT1d

Pharmalittle: We’re reading about Regeneron buying 23andMe, the Novavax Covid shot, and more

The FDA finally approved Novavax's Covid-19 vaccine, but placed restrictions on it that its two competitors in the U.S. do not face